Latest News Archive
Please select Category, Year, and then Month to display items
12 January 2024
|
Story Nonsindiswe Qwabe
|
Photo Sonia Small
Since joining the UFS in 2008, Dr Grey Magaiza has worked extensively on approaches that can foster the socio-economic transformation of societies.
“The future should be one where communities can decide on their development agenda and futures. That’s the most important for me.” Dr Grey Magaiza, Deputy Director of the Centre for Gender and Africa Studies (CGAS) and Head of the Community Development programme on the Qwaqwa Campus, is passionate about capacitating communities to be agents of change and advancement. His vision for the future emphasises the empowerment of communities to take charge of their development by actively participating in decision making and the implementation of development projects that can improve their lives.
Since joining the UFS in 2008, Dr Magaiza has worked extensively on approaches that can foster the socio-economic transformation of societies. Over the years, he has crafted his research speciality into one that he is most proud of – being an interdisciplinary scientist immersed in the development of communities.
“I’m in a fortunate position of researching what I like. I say ‘fortunate’, because I’ve taken the time to understand what I’m passionate about, which is the overall field of rural livelihoods and livelihood futures – in short, community development. My research starts from an engaged university, understanding the elements that a university must use to enhance transformation and relevance to its immediate community in terms of development.”
One of the ways he has done this is by looking at social entrepreneurship as a development approach for young people in a rural setting. Through workshops with non-profit and civic organisations in Qwaqwa, Dr Magaiza has been helping these organisations to map out their needs and actively meet them through the involvement and support of external role players.
“We understand that communities are part of the national development agenda, but even that national agenda respects community knowledge and intentions and allows communities to shape their identity. A critical enabler of this is community organising. You bring back the capacity in communities to have dialogues on issues affecting them as spaces for engagement, knowledge exchange, and for people to just talk about their way forward.”
By enabling communities to define their development agenda, they can address their specific needs, challenges, and aspirations, he said. “When I look at livelihood futures, it’s quite an exciting aspect of my work – it’s like looking into a fortune tellers’ globe, because you’re not deciding for communities what they should do, but the communities themselves take those decisions.”
UFS cardiac team leading with project
2017-05-31
Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin
A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.
An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.
“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.
International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.
“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.
“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.
“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”
Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”
Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.